Patent ID: 8236750
Filing Date: 2012-08-07
Classification: A61K,A61P

Abstract:
1. A pharmaceutical composition comprising: a therapeutically effective amount of a pulmonary surfactant selected from the group consisting of CUROSURF®, SURVANTA®, ALVEOFACT®, SURFACTEN@, INFASURF®, BLES®, SINAPULTIDE® and a pulmonary surfactant comprising phospholipids and pulmonary surfactant protein, the pulmonary surfactant protein being selected from the group consisting of Surfactant Protein-B (SP-B), Surfactant Protein-C (SP-C) and LUSUPULTIDE (rSP-C (FF/I)); a therapeutically effective amount of a peptide consisting of the amino acids according to SEQ ID NO: 2 or the amino acids according to SEQ ID NO: 3 and a pharmaceutically acceptable carrier.